Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


13.03.2017

2 Br J Dermatol
1 Cancer Lett
1 Eur J Dermatol
1 Gene
2 Lancet Oncol
3 Melanoma Res
2 Oncogene
1 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Dermatol

  1. RICHTIG G, Hoeller C, Kashofer K, Aigelsreiter A, et al
    Beyond the BRAFV600E hotspot - Biology and clinical implications of rare BRAF gene mutations in melanoma patients.
    Br J Dermatol. 2017 Mar 9. doi: 10.1111/bjd.15436.
    PubMed     Text format     Abstract available

  2. NILSEN LT, Hannevik M, Veierod MB
    Ultraviolet exposure from indoor tanning devices: a systematic review.
    Br J Dermatol. 2016;174:730-40.
    PubMed     Text format     Abstract available


    Cancer Lett

  3. XU DH, Zhu Z, Xiao H, Wakefield MR, et al
    Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.
    Cancer Lett. 2017 Feb 28. pii: S0304-3835(17)30131.
    PubMed     Text format     Abstract available


    Eur J Dermatol

  4. VILDY S, Nguyen JM, Gaultier A, Knol AC, et al
    Impact of the time interval between lymph node recurrence and lymphadenectomy on melanoma patient survival.
    Eur J Dermatol. 2017 Mar 2. doi: 10.1684/ejd.2016.2955.
    PubMed     Text format     Abstract available


    Gene

  5. MAURO JA, Yavorski JM, Blanck G
    Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genes.
    Gene. 2017 Feb 28. pii: S0378-1119(17)30126-9. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    Lancet Oncol

  6. PAULSON KG, Thompson JA
    A second chance for success with BRAF and MEK inhibitors in melanoma.
    Lancet Oncol. 2017 Mar 3. pii: S1470-2045(17)30151.
    PubMed     Text format    

  7. SCHREUER M, Jansen Y, Planken S, Chevolet I, et al
    Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial.
    Lancet Oncol. 2017 Mar 3. pii: S1470-2045(17)30171.
    PubMed     Text format     Abstract available


    Melanoma Res

  8. BLASIG H, Bender C, Hassel JC, Eigentler TK, et al
    Reinduction of PD1-inhibitor therapy: first experience in eight patients with metastatic melanoma.
    Melanoma Res. 2017 Mar 2. doi: 10.1097/CMR.0000000000000341.
    PubMed     Text format     Abstract available

  9. FUKUDA K, Funakoshi T, Sakurai T, Nakamura Y, et al
    Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma.
    Melanoma Res. 2017 Mar 3. doi: 10.1097/CMR.0000000000000342.
    PubMed     Text format     Abstract available

  10. FALLENI M, Savi F, Tosi D, Agape E, et al
    M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.
    Melanoma Res. 2017 Mar 7. doi: 10.1097/CMR.0000000000000352.
    PubMed     Text format     Abstract available


    Oncogene

  11. ZHAI Z, Liu W, Kaur M, Luo Y, et al
    NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  12. YANG H, Kircher DA, Kim KH, Grossmann AH, et al
    Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    Oncol Rep

  13. ZHAO G, Han X, Cheng W, Ni J, et al
    Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5450.
    PubMed     Text format     Abstract available


    PLoS One

  14. TUDOR D, Nenu I, Filip GA, Olteanu D, et al
    Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy.
    PLoS One. 2017;12:e0173241.
    PubMed     Text format     Abstract available


  15. Correction: Comprehensive measurement of UVB-induced non-melanoma skin cancer burden in mice using photographic images as a substitute for the caliper method.
    PLoS One. 2017;12:e0173718.
    PubMed     Text format     Abstract available

  16. WESSELS D, Lusche DF, Voss E, Kuhl S, et al
    Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.
    PLoS One. 2017;12:e0173400.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: